NCT04549844

Brief Summary

Strabismus is a common ophthalmic problem in Egypt that usually requires surgical correction. This surgery primarily aims to improve alignment of visual axis but may be required only for cosmetic reasons. General anesthesia is mandatory for most cases however a concomitant local anesthetics administration is preferable to improve patient satisfaction, decrease postoperative analgesic requirements and reduce post-operative pain. Oculocardiac reflex is a noted serious complication that accompanies such surgeries and may be life threatening. Oculocardiac reflex (OCR) is one of the main challenges that face anesthesiologists during strabismus surgery. The incidence of OCR varies from 16 to 82 % in strabismus surgeries and this wide range does depend on the anesthetic agents, premedications, and the definition of OCR being used. Maintenance of adequate depth of anesthesia and the use of anti-cholinergic is the mainstay to reduce this risk. OCR is usually defined as a decrease in heart rate of more than 20 % from the baseline. This reflex is triggered by the pressure on the extra ocular muscles (EOM) or eyeball, orbital hematoma or trauma, the afferent limb is from orbital contents to ciliary ganglion then to the sensory nucleus of the trigeminal nerve near the fourth ventricle through the ophthalmic division of the trigeminal nerve. The main response of this reflex is transmitted through the vagus to the heart. This vagal stimulation leads to a decrease in heart rate (sinus bradycardia), contractility and arrhythmias such as atrioventricular block, ventricular fibrillation up to cardiac arrest. The incidence of the OCR decreases with age and tends to be more pronounced in young healthy patients. It has been suggested that the anesthetic agents used during surgery influence the incidence of OCR. To date, the only successful method to interrupt an OCR is to stop the EOM traction, and then proceed with caution as surgery continues. Depth of anesthesia is another presumed factor having an impact on reducing of OCR incidence. The response to surgical stimulus can be minimized or stopped with the help of peribulbar block.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2020

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

1.1 years

First QC Date

September 4, 2020

Last Update Submit

September 13, 2020

Conditions

Keywords

Peribulbar blockOculocardiac reflex

Outcome Measures

Primary Outcomes (1)

  • The incidence of Oculocardiac reflex .

    Occurence of bradycardia with heart rate decrease by 20% from baseline value or if dysrhythmias or sinus arrest after traction on extraocular muscles

    3 minutes after traction on extraocular muscles during squint surgery

Secondary Outcomes (11)

  • Degree of post operative pain

    2 hours post operatively

  • Degree of post operative pain

    4 hours postoperatively

  • Degree of post operative pain

    6 hours postoperatively

  • Degree of post operative pain

    12 hours postoperatively

  • Degree of post operative pain

    24 hours postoperatively

  • +6 more secondary outcomes

Other Outcomes (4)

  • Patient's age

    1 hour before operation

  • Patient's weight

    1 hour before operation

  • Patient's height

    1 hour before operation

  • +1 more other outcomes

Study Arms (2)

the intervention group (G A)

ACTIVE COMPARATOR

Group general anaesthesia plus peribulbar block : Total 35 cases who will receive general anesthesia with peribulbar block (bupivacaine 0.5 % xylocaine 2% hyaluronidase with total volume 0.06 mg \\kg (bupivacaine : (xylocaine :hyaluronidase ) 1:1) Patients in peribulbar block group will receive lidocaine 2%, bupivacaine 0.5% and hyaluronidase with total volume 0.06 ml/kg keeping the ratio 1: 1 between lidocaine combined with hyaluronidase and bupivacaine by 24 Gauge needle after induction of general anesthesia and before start of surgery.

Drug: Bupivacaine

the control group (G B )

PLACEBO COMPARATOR

General group: Total 35 cases who will receive general anesthesia only, i.e., without peribulbar block. (Fentanyl 1µg\\kg, atracurium 0.5 mg\\kg and propofol 2mg \\kg. After adequate pre-oxygenation, Induction will be accomplished with the injection of propofol 2 mg/kg and Fentanyl 1 µg/kg IV. Endotracheal intubation will be facilitated by the intravenous injection of 0.5 mg/kg atracurium. General anesthesia will be maintained by mechanical ventilation with oxygen and air (50:50), isoflurane.

Drug: Bupivacaine

Interventions

After adequate pre-oxygenation, Induction will be accomplished with the injection of propofol 2 mg/kg and Fentanyl 1 µg/kg IV. Endotracheal intubation will be facilitated by the intravenous injection of 0.5 mg/kg atracurium. General anesthesia will be maintained by mechanical ventilation with oxygen and air (50:50), isoflurane. Patients in peribulbar block group will receive lidocaine 2%, bupivacaine 0.5% and hyaluronidase with total volume 0.06 ml/kg keeping the ratio 1: 1 between lidocaine combined with hyaluronidase and bupivacaine by 24 Gauge needle after induction of general anesthesia and before start of surgery.

Also known as: xylocaine hyaluronidase
the control group (G B )the intervention group (G A)

Eligibility Criteria

Age10 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients aged 10 years to 50 years
  • American society association (ASA) physical status I, II
  • Patient scheduled for a unilateral strabismus surgery.

You may not qualify if:

  • Refusal of local anesthesia.
  • Contraindications of local anesthesia e.g. allergy or hypersensitivity to local anesthetics or orbital inflammation .
  • Pregnancy
  • Glaucoma
  • Communication barrier between physician and patient e.g. impaired hearing, impaired mental status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine -Fayoum University

Al Fayyum, 1234, Egypt

RECRUITING

Related Publications (2)

  • Karanovic N, Carev M, Ujevic A, Kardum G, Dogas Z. Association of oculocardiac reflex and postoperative nausea and vomiting in strabismus surgery in children anesthetized with halothane and nitrous oxide. Paediatr Anaesth. 2006 Sep;16(9):948-54. doi: 10.1111/j.1460-9592.2006.01865.x.

    PMID: 16918657BACKGROUND
  • Kosaka M, Asamura S, Kamiishi H. Oculocardiac reflex induced by zygomatic fracture; a case report. J Craniomaxillofac Surg. 2000 Apr;28(2):106-9. doi: 10.1054/jcms.2000.0107.

    PMID: 10958423BACKGROUND

MeSH Terms

Conditions

Strabismus

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Ocular Motility DisordersCranial Nerve DiseasesNervous System DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Maged Labib Boulos, MD

    faculty of medicine -fayoum university

    PRINCIPAL INVESTIGATOR
  • Khalid Gamal Abu eleinen, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

mahmoud Ramadan Ahmed, Bch

CONTACT

Mohamed yehia Abd Elatif, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anaesthesilogy

Study Record Dates

First Submitted

September 4, 2020

First Posted

September 16, 2020

Study Start

August 14, 2019

Primary Completion

September 14, 2020

Study Completion

October 14, 2020

Last Updated

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations